Xp11 translocation renal cell carcinoma (tRCC) is a female-predominant kidney cancer
driven by translocations between the TFE3 gene on chromosome Xp11. 2 and partner …

Gene fusions involving TFE3 defines the “Xp11. 2 translocations” subclass of renal cell
carcinomas (RCCs) belonging to the MiT family translocation RCC. Four recurrent TFE3 …

Background Renal cell carcinoma (RCC) associated with Xp11. 2 translocation/TFE3 gene
fusion is a rare and new subtype of RCC and was classified by the WHO in 2004. Since …

Background Translocation renal cell carcinomas (TFE3 RCC) are associated with variable
genetic rearrangements of the TFE3 gene on chromosome Xp11. 2. Translocation tumors …

Xp11 (TFE3) translocation renal cell carcinoma (RCC) is officially recognized as a distinct
subtype of RCC in the 2004 WHO classification. This neoplasm is characterized by several …

Xp11 translocation renal cell carcinomas harbor chromosome translocations involving the
Xp11 breakpoint, resulting in gene fusions involving the TFE3 gene. The most common …

TFE3-translocation renal cell carcinoma (TFE3-tRCC) is a rare and heterogeneous subtype
of kidney cancer with no standard treatment for advanced disease. We describe …

Background Renal cell carcinoma (RCC) associated with Xp11. 2 translocation/TFE3 gene
fusion (Xp11. 2 RCC) is a rare subtype of RCC which is firstly described as a distinct entity in …

TFE3 translocation renal cell carcinoma (tRCC) is defined by chromosomal translocations
involving the TFE3 transcription factor at chromosome Xp11. 2. Genetically proven TFE3 …

Xp11 translocation renal cell carcinoma (RCC) are defined by chromosome translocations
involving the Xp11 breakpoint which results in one of a variety of TFE3 gene fusions. TFE3 …